a few facts, page-3

pogs,

most undervalued medical stock on asx ... damn right ... hard to believe it is 50% lower than it was when all we had was pulmosonix program. so 18 months later, there are 60million shares, $3m in the bank, one business growing rapidly and bringing in cash from UK, Asia and domestically and another business on the verge of signing major commercial deals. $10m market cap is a joke when you consider what VCR is capped at with their products years nowhere near as advanced.

they need some good growth figures to ram home the message, and get their new PR company cracking on selling the story. all the nations doctors are in; can't be long now until management get a big fish aboard to get the sp leaping higher.

what announcement will re-rate PBI?

* cochlear simulator finished and ready to start training bionic ear surgeons in China and the world
* trauma simulator finished and being sold to Israeli/US interests
* commercial deal for emphasyma diagnostic device
* commercial deal for baby airway clear/sleep apnea devices
* first sales of 'world first' epidural simulator into UK, Asia or by licence partner in United States.
* Royal Colege of Surgeons in UK new training HQ to be fully equipped by medicvision
* More Chinese hospitals sign medicvision to consultancies.
* Revenues for September quarter double, forcast to double again in next quarter
* commercial deal for any of five new pulmosonix applications they are working on
* corporate action to spin medicvision into a seperate UK listed entity - share split for PBI holders.
* federal government announces new pulmosonix funding
* state federal govt health ministers announce new funding for simulation training to meet the shortgae of trained healthcare workers
* underwriting of options ensures $9m in cash in Dec
* blokes sells his PBIO's, thus ensuring they hit $1.